Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06450301

Senescent Endometrial Cells in Patients with Thin Endometrial Lining

Is Thin Endometrial Lining Associated with Senescent Endometrial Cells

Status
Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Trio Fertility · Academic / Other
Sex
Female
Age
18 Years – 39 Years
Healthy volunteers
Accepted

Summary

The goal of this observational study is to determine if thin endometrial lining that is unresponsive to estrogen might be associated with the presence of senescent cells in patients following long-term use of oral contraceptives. The main question it aims to answer is: Are there any senescent cells present in thin endometrial lining? During the luteal phase of the cycle, participants will will undergo: * Gynecologic US to measure the endometrial lining thickness and pattern. * Endometrial biopsy with Pipelle catheter

Detailed description

The investigators hypothesized that senescent cells in the endometrium may be the cause of the failure of thin endometrium to respond to normal growth stimuli such as estrogen. The outcome that research team anticipate to measure is the percentage of senescent cells in the endometrial biopsies of women with thin endometrium compared to the control group biopsies.

Conditions

Interventions

TypeNameDescription
PROCEDUREEndometrial BiopsyAn endometrial biopsy is the removal of a small piece of tissue from the endometrium, which is the lining of the uterus. Endometrial biopsies are commonly done to check for the window of implantation, to determine ovulation or for enhancing implantation (procedure called endometrial scratching). For this purpose, we will use a "Pipelle" catheter. This procedure is very common in gynecologic practice and generally considered safe. In most of the cases this procedure is indicated for evaluation of irregular vaginal bleeding, vaginal bleeding in post-menopausal women and for infertility related problems (recurrent implantation failures for example).

Timeline

Start date
2024-09-11
Primary completion
2027-01-01
Completion
2027-06-01
First posted
2024-06-10
Last updated
2024-11-21

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT06450301. Inclusion in this directory is not an endorsement.